|
1.
|
Warren S: The immediate causes of death in
cancer. Am J Med Sci. 184:610–615. 1932. View Article : Google Scholar
|
|
2.
|
Argiles JM, Alvarez B and Lopez-Soriano
FJ: The metabolic basis of cancer cachexia. Med Res Rev.
17:477–498. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Argiles JM and Lopez-Soriano FJ: Why do
cancer cells have such a high glycolytic rate? Med Hypotheses.
32:151–155. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Harvey KB, Bothe A Jr and Blackburn GL:
Nutritional assessment and patient outcome during oncological
therapy. Cancer. 43:2065–2069. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nixon DW, Heymsfield SB, Cohen AE, et al:
Protein-calorie undernutrition in hospitalized cancer patients. Am
J Med. 68:683–690. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
DeWys W: Management of cancer cachexia.
Semin Oncol. 12:452–460. 1985.
|
|
7.
|
Argiles JM, Garcia-Martinez C, Llovera M
and Lopez-Soriano FJ: The role of cytokines in muscle wasting: its
relation with cancer cachexia. Med Res Rev. 12:637–652. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Van Royen M, Carbo N, Busquets S, et al:
DNA fragmentation occurs in skeletal muscle during tumor growth: a
link with cancer cachexia? Biochem Biophys Res Commun. 270:533–537.
2000.PubMed/NCBI
|
|
9.
|
Kim YS and Sainz RD: Beta-adrenergic
agonists and hypertrophy of skeletal muscles. Life Sci. 50:397–407.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Stock MJ and Rothwell NJ: Effects of
beta-adrenergic agonists on metabolism and body composition.
Control and Manipulation of Animal Growth. Buttery PJ, Hayes NB and
Lindsay DB: Butterworths; London: pp. 249–257. 1985
|
|
11.
|
Agbenyega ET and Wareham AC: Effect of
clenbuterol on skeletal muscle atrophy in mice induced by the
glucocorticoid dexamethasone. Comp Biochem Physiol Comp Physiol.
102:141–145. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Rajab P, Fox J, Riaz S, Tomlinson D, Ball
D and Greenhaff PL: Skeletal muscle myosin heavy chain isoforms and
energy metabolism after clenbuterol treatment in the rat. Am J
Physiol Regul Integr Comp Physiol. 279:R1076–R1081. 2000.PubMed/NCBI
|
|
13.
|
Hinkle RT, Hodge KM, Cody DB, Sheldon RJ,
Kobilka BK and Isfort RJ: Skeletal muscle hypertrophy and
anti-atrophy effects of clenbuterol are mediated by the
beta2-adrenergic receptor. Muscle Nerve. 25:729–734. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wineski LE, von Deutsch DA, Abukhalaf IK,
Pitts SA, Potter DE and Paulsen DF: Muscle-specific effects of
hindlimb suspension and clenbuterol in mature male rats. Cells
Tissues Organs. 171:188–198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yang YT and McElligott MA: Multiple
actions of beta-adrenergic agonists on skeletal muscle and adipose
tissue. Biochem J. 261:1–10. 1989.PubMed/NCBI
|
|
16.
|
Mersmann HJ: Overview of the effects of
beta-adrenergic receptor agonists on animal growth including
mechanisms of action. J Anim Sci. 76:160–172. 1998.PubMed/NCBI
|
|
17.
|
Anderson GP: Pharmacology of formoterol:
an innovative bronchodilator. Agents Actions Suppl. 34:97–115.
1991.PubMed/NCBI
|
|
18.
|
Mahler DA: The effect of inhaled
beta2-agonists on clinical outcomes in chronic obstructive
pulmonary disease. J Allergy Clin Immunol. 110:S298–S303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Busquets S, Figueras MT, Fuster G, et al:
Anticachectic effects of formoterol: a drug for potential treatment
of muscle wasting. Cancer Res. 64:6725–6731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tessitore L, Costelli P, Bonetti G and
Baccino FM: Cancer cachexia, malnutrition, and tissue protein
turnover in experimental animals. Arch Biochem Biophys. 306:52–58.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Sinis N, Guntinas-Lichius O, Irintchev A,
et al: Manual stimulation of forearm muscles does not improve
recovery of motor function after injury to a mixed peripheral
nerve. Exp Brain Res. 185:469–483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zangarelli A, Chanseaume E, Morio B, et
al: Synergistic effects of caloric restriction with maintained
protein intake on skeletal muscle performance in 21-month-old rats:
a mitochondria-mediated pathway. FASEB J. 20:2439–2450. 2006.
View Article : Google Scholar
|
|
23.
|
Fuster G, Busquets S, Ametller E, et al:
Are peroxisome proliferator-activated receptors involved in
skeletal muscle wasting during experimental cancer cachexia? Role
of beta2-adrenergic agonists. Cancer Res. 67:6512–6519. 2007.
View Article : Google Scholar
|
|
24.
|
Costelli P, Garcia-Martinez C, Llovera M,
et al: Muscle protein waste in tumor-bearing rats is effectively
antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of
the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest.
95:2367–2372. 1995. View Article : Google Scholar
|
|
25.
|
Ametller E, Busquets S, Fuster G, et al:
Formoterol may activate rat muscle regeneration during cancer
cachexia. Insciences J. 1:1–17. 2011. View Article : Google Scholar
|
|
26.
|
Lanigan C, Howes TQ, Borzone G, Vianna LG
and Moxham J: The effects of beta 2-agonists and caffeine on
respiratory and limb muscle performance. Eur Respir J. 6:1192–1196.
1993.PubMed/NCBI
|
|
27.
|
Signorile JF, Banovac K, Gomez M, Flipse
D, Caruso JF and Lowensteyn I: Increased muscle strength in
paralyzed patients after spinal cord injury: effect of beta-2
adrenergic agonist. Arch Phys Med Rehabil. 76:55–58. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Marzabal M, Garcia-Martinez C, Comas J,
Lopez-Soriano FJ and Argiles JM: A flow cytometric study of the rat
Yoshida AH-130 ascites hepatoma. Cancer Lett. 72:169–173. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Toledo M, Busquets S, Sirisi S, et al:
Cancer cachexia: physical activity and muscle force in
tumour-bearing rats. Oncol Rep. 25:189–193. 2011.PubMed/NCBI
|
|
30.
|
Argiles JM, Busquets S, Toledo M and
Lopez-Soriano FJ: The role of cytokines in cancer cachexia. Curr
Opin Support Palliat Care. 3:263–268. 2009. View Article : Google Scholar
|
|
31.
|
Llovera M, Garcia-Martinez C,
Lopez-Soriano J, et al: Role of TNF receptor 1 in protein turnover
during cancer cachexia using gene knockout mice. Mol Cell
Endocrinol. 142:183–189. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Argiles JM, Busquets S and Lopez-Soriano
FJ: Cytokines as mediators and targets for cancer cachexia. Cancer
Treat Res. 130:199–217. 2006. View Article : Google Scholar : PubMed/NCBI
|
